Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
The Lancet. Infectious diseases
View this publicationThe Lancet. Infectious diseases
View this publicationImmunity
View this publicationNature reviews. Neurology
View this publicationNature cell biology
View this publicationFrontiers in immunology
View this publicationHistopathology
View this publicationIndian journal of dermatology
View this publicationAllergy
View this publicationInternational journal of radiation oncology, biology, physics
View this publicationBMC biology
View this publication